Short Interest in The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Rises By 21.0%

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) saw a large growth in short interest in October. As of October 15th, there was short interest totalling 9,800 shares, a growth of 21.0% from the September 30th total of 8,100 shares. Based on an average daily volume of 21,900 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock traded down $0.09 during midday trading on Tuesday, reaching $19.93. The stock had a trading volume of 4,936 shares, compared to its average volume of 21,391. The company has a fifty day moving average price of $19.90 and a two-hundred day moving average price of $18.90. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 12 month low of $15.90 and a 12 month high of $20.85.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, November 1st will be issued a dividend of $0.2891 per share. The ex-dividend date of this dividend is Friday, November 1st. This represents a $1.16 annualized dividend and a dividend yield of 5.80%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.